Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.South Korea |
First Approval Date07 Sep 2007 |
100 Clinical Results associated with Guilin Pharmaceutical Group Co., Ltd.
0 Patents (Medical) associated with Guilin Pharmaceutical Group Co., Ltd.
100 Deals associated with Guilin Pharmaceutical Group Co., Ltd.
100 Translational Medicine associated with Guilin Pharmaceutical Group Co., Ltd.